Accell Gene Therapy is a fully integrated therapeutic system that enables direct transfer of genes into cells in vivo or ex vivo . Agracetus has developed unique, cost-advantaged bioreactor production systems. The company intends to capitalize its cost-advantaged proprietary technology and to position itself as a producer and supplier of bulk products to the biopharmaceutical and enzyme industries.
Current development is focused on high-valued therapeutic proteins.
Agracetus is the world leader in genetically engineered cotton. The company is focusing its technology on development of high-performance fibers that will combine the preferred appearance and texture of cotton with enhanced fiber properties. These fibers will improve textile processing economics and environmental compatibility as well as enable entirely new fiber product opportunities.